These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33802253)

  • 41. Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation.
    Van Noord T; Crijns HJ; van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
    BMC Cardiovasc Disord; 2005 Jan; 5(1):3. PubMed ID: 15667649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].
    Potpara T; Marinković-Erić J; Grujić M; Radojković-Cirović B; Vujisić-Tesić B; Petrović M
    Srp Arh Celok Lek; 2002; 130(5-6):189-92. PubMed ID: 12395441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left atrial electromechanical conduction time can predict six-month maintenance of sinus rhythm after electrical cardioversion in persistent atrial fibrillation by Doppler tissue echocardiography.
    Park SM; Kim YH; Choi JI; Pak HN; Kim YH; Shim WJ
    J Am Soc Echocardiogr; 2010 Mar; 23(3):309-14. PubMed ID: 20138472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of Natriuretic Peptides with Left Atrial Structure and Function within 1 Month after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation.
    Karaliute R; Jureviciute J; Jurgaityte J; Stanaitiene G; Mizariene V; Kazakevicius T; Urboniene D; Kavoliuniene A
    Biomed Res Int; 2019; 2019():7636195. PubMed ID: 31008112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrical cardioversion of persistent atrial fibrillation: acute and long-term results stratified according to arrhythmia duration.
    Toso E; Blandino A; Sardi D; Battaglia A; Garberoglio L; Miceli S; Azzaro G; Capello AL; Gaita F
    Pacing Clin Electrophysiol; 2012 Sep; 35(9):1126-34. PubMed ID: 22758783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
    Kapoor A; Kumar S; Singh RK; Pandey CM; Sinha N
    J Heart Valve Dis; 2002 Nov; 11(6):802-9. PubMed ID: 12479281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation.
    Wałek P; Gorczyca I; Sielski J; Wożakowska-Kapłon B
    PLoS One; 2020; 15(8):e0238002. PubMed ID: 32822402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of sinus rhythm at time of ablation in patients with persistent atrial fibrillation undergoing pulmonary vein isolation is associated with improved long-term arrhythmia outcomes.
    Eberly LA; Lin A; Park J; Khoshnab M; Garg L; Chee J; Kallan MJ; Walsh K; Supple GE; Schaller RD; Santangeli P; Riley MP; Nazarian S; Arkles J; Hyman M; Lin D; Guandalini G; Kumareswaran R; Deo R; Zado ES; Epstein A; Frankel DS; Callans DJ; Marchlinski FE; Dixit S
    J Interv Card Electrophysiol; 2023 Sep; 66(6):1455-1464. PubMed ID: 36525168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation.
    Dong Z; Yao H; Miao Z; Wang H; Xie R; Wang Y; Shang Y; Gong C; Liang Z
    Biomed Rep; 2017 Jun; 6(6):686-690. PubMed ID: 28584642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of electrical cardioversion on 1-year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation.
    Dong Z; Du X; Hou XX; He L; Dong JZ; Ma CS
    Clin Cardiol; 2021 Aug; 44(8):1128-1138. PubMed ID: 34101841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
    Tieleman RG; Van Gelder IC; Bosker HA; Kingma T; Wilde AA; Kirchhof CJ; Bennekers JH; Bracke FA; Veeger NJ; Haaksma J; Allessie MA; Crijns HJ
    Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preprocedural restoration of sinus rhythm and left atrial strain predict outcomes of catheter ablation for long-standing persistent atrial fibrillation.
    Hanaki Y; Machino-Ohtsuka T; Aonuma K; Komatsu Y; Machino T; Yamasaki H; Igarashi M; Sekiguchi Y; Nogami A; Ieda M
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1709-1718. PubMed ID: 32391641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation.
    Castrichini M; Restivo L; Fabris E; Massa L; Di Meola R; Beltrame D; De Luca A; Korcova R; Milo M; Sinagra G
    J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):626-630. PubMed ID: 33882536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frontal plane QRS-T angle predicts early recurrence of acute atrial fibrillation after successful pharmacological cardioversion with intravenous amiodarone.
    Eyuboglu M; Celik A
    J Clin Pharm Ther; 2021 Dec; 46(6):1750-1756. PubMed ID: 34480487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does conduction heterogeneity determine the supervulnerable period after atrial fibrillation?
    Heida A; van der Does WFB; van Schie MS; van Staveren LN; Taverne YJHJ; Bogers AJJC; de Groot NMS
    Med Biol Eng Comput; 2023 Apr; 61(4):897-908. PubMed ID: 36223000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.
    Müssigbrodt A; John S; Kosiuk J; Richter S; Hindricks G; Bollmann A
    Europace; 2016 Jan; 18(1):51-6. PubMed ID: 26056189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
    Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
    Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery.
    Skoularigis J; Röthlisberger C; Skudicky D; Essop MR; Wisenbaugh T; Sareli P
    Am J Cardiol; 1993 Aug; 72(5):423-7. PubMed ID: 8352186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.